168 related articles for article (PubMed ID: 32420368)
1. Identification of Prognostic Immune Genes in Bladder Urothelial Carcinoma.
Su Q; Sun Y; Zhang Z; Yang Z; Qiu Y; Li X; Mo W
Biomed Res Int; 2020; 2020():7510120. PubMed ID: 32420368
[TBL] [Abstract][Full Text] [Related]
2. Identification of immune-related genes as prognostic factors in bladder cancer.
Zhu J; Wang H; Ma T; He Y; Shen M; Song W; Wang JJ; Shi JP; Wu MY; Liu C; Wang WJ; Huang YQ
Sci Rep; 2020 Nov; 10(1):19695. PubMed ID: 33184436
[TBL] [Abstract][Full Text] [Related]
3. Construction of Protein-related Risk Score Model in Bladder Urothelial Carcinoma.
Luo Q; Zhang X
Biomed Res Int; 2020; 2020():7147824. PubMed ID: 32802870
[TBL] [Abstract][Full Text] [Related]
4. Development of a prognostic index and screening of prognosis related genes based on an immunogenomic landscape analysis of bladder cancer.
Qu G; Liu Z; Yang G; Xu Y; Xiang M; Tang C
Aging (Albany NY); 2021 Apr; 13(8):12099-12112. PubMed ID: 33888644
[TBL] [Abstract][Full Text] [Related]
5. Establishment of a novel risk score model by comprehensively analyzing the immunogen database of bladder cancer to indicate clinical significance and predict prognosis.
Liu L; Hu J; Wang Y; Sun T; Zhou X; Li X; Ma F
Aging (Albany NY); 2020 Jun; 12(12):11967-11989. PubMed ID: 32570217
[TBL] [Abstract][Full Text] [Related]
6. LGALS4 as a Prognostic Factor in Urothelial Carcinoma of Bladder Affects Cell Functions.
Ding Y; Cao Q; Wang C; Duan H; Shen H
Technol Cancer Res Treat; 2019 Jan; 18():1533033819876601. PubMed ID: 31558111
[TBL] [Abstract][Full Text] [Related]
7. Chromatin-regulatory genes served as potential therapeutic targets for patients with urothelial bladder carcinoma.
Qiu JG; Shi DY; Liu X; Zheng XX; Wang L; Li Q
J Cell Physiol; 2019 May; 234(5):6976-6982. PubMed ID: 30317582
[TBL] [Abstract][Full Text] [Related]
8. Identification of five long noncoding RNAs signature and risk score for prognosis of bladder urothelial carcinoma.
Zhang C; Li Z; Hu J; Qi F; Li X; Luo J
J Cell Biochem; 2020 Jan; 121(1):856-866. PubMed ID: 31373406
[TBL] [Abstract][Full Text] [Related]
9. Identification of a tumor microenvironment-related seven-gene signature for predicting prognosis in bladder cancer.
Wang Z; Tu L; Chen M; Tong S
BMC Cancer; 2021 Jun; 21(1):692. PubMed ID: 34112144
[TBL] [Abstract][Full Text] [Related]
10. RBP7 Regulated by EBF1 Affects Th2 Cells and the Oocyte Meiosis Pathway in Bone Metastases of Bladder Urothelial Carcinoma.
Liu Y; Fan M; Xian S; Hu P; Zhang M; Zhang X; Zhang H; Zhang J; Dai L; Lin M; Mei W; Huang D; Huang R; Zhang J; Huang Z
Front Biosci (Landmark Ed); 2023 Aug; 28(8):189. PubMed ID: 37664915
[TBL] [Abstract][Full Text] [Related]
11. Identification of an immune-related long non-coding RNA signature and nomogram as prognostic target for muscle-invasive bladder cancer.
Song Y; Jin D; Chen J; Luo Z; Chen G; Yang Y; Liu X
Aging (Albany NY); 2020 Jun; 12(12):12051-12073. PubMed ID: 32579540
[TBL] [Abstract][Full Text] [Related]
12. Development of prognostic signature based on immune-related genes in muscle-invasive bladder cancer: bioinformatics analysis of TCGA database.
Jin K; Qiu S; Jin D; Zhou X; Zheng X; Li J; Liao X; Yang L; Wei Q
Aging (Albany NY); 2021 Jan; 13(2):1859-1871. PubMed ID: 33465047
[TBL] [Abstract][Full Text] [Related]
13. Prognostic Signature of Alternative Splicing Events in Bladder Urothelial Carcinoma Based on Spliceseq Data from 317 Cases.
He RQ; Zhou XG; Yi QY; Deng CW; Gao JM; Chen G; Wang QY
Cell Physiol Biochem; 2018; 48(3):1355-1368. PubMed ID: 30048970
[TBL] [Abstract][Full Text] [Related]
14. A robust signature of immune-related long non-coding RNA to predict the prognosis of bladder cancer.
Lai C; Wu Z; Li Z; Yu H; Li K; Tang Z; Liu C; Xu K
Cancer Med; 2021 Sep; 10(18):6534-6545. PubMed ID: 34374227
[TBL] [Abstract][Full Text] [Related]
15. Identifying Potential Prognostic Markers for Muscle-Invasive Bladder Urothelial Carcinoma by Weighted Gene Co-Expression Network Analysis.
Feng Y; Jiang Y; Wen T; Meng F; Shu X
Pathol Oncol Res; 2020 Apr; 26(2):1063-1072. PubMed ID: 31011911
[TBL] [Abstract][Full Text] [Related]
16. RNA-Sequencing Data Reveal a Prognostic Four-lncRNA-Based Risk Score for Bladder Urothelial Carcinoma: An in Silico Update.
He RQ; Huang ZG; Li TY; Wei YP; Chen G; Lin XG; Wang QY
Cell Physiol Biochem; 2018; 50(4):1474-1495. PubMed ID: 30359990
[TBL] [Abstract][Full Text] [Related]
17. Genome-wide screening of abberant methylated drivers combined with relative risk loci in bladder cancer.
Zhang C; Shen K; Zheng Y; Qi F; Luo J
Cancer Med; 2020 Jan; 9(2):768-782. PubMed ID: 31794632
[TBL] [Abstract][Full Text] [Related]
18. Identification of 9-Core Immune-Related Genes in Bladder Urothelial Carcinoma Prognosis.
Na L; Bai Y; Sun Y; Wang Z; Wang W; Yuan L; Zhao C
Front Oncol; 2020; 10():1142. PubMed ID: 32733809
[No Abstract] [Full Text] [Related]
19. CD8
Chen X; Xu R; He D; Zhang Y; Chen H; Zhu Y; Cheng Y; Liu R; Zhu R; Gong L; Xiao M; Wang Z; Deng L; Cao K
Oncogene; 2021 Oct; 40(43):6223-6234. PubMed ID: 34552192
[TBL] [Abstract][Full Text] [Related]
20. A novel 6-gene signature derived from tumor-infiltrating T cells and neutrophils predicts survival of bladder urothelial carcinoma.
Zou X; Wei Y; Qi T; Wang X; Zuo W; Wang T; Zhu W; Zhou X
Aging (Albany NY); 2021 Dec; 13(23):25496-25517. PubMed ID: 34905506
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]